BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22298013)

  • 1. Anatomical and visual results of transconjunctival sutureless vitrectomy using subconjunctival anesthesia performed on select patients taking anticoagulant and antiplatelet agents.
    Malik AI; Foster RE; Correa ZM; Petersen MR; Miller DM; Riemann CD
    Retina; 2012 May; 32(5):905-11. PubMed ID: 22298013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of primary rhegmatogenous retinal detachment using 25-gauge transconjunctival sutureless vitrectomy.
    Lai MM; Ruby AJ; Sarrafizadeh R; Urban KE; Hassan TS; Drenser KA; Garretson BR
    Retina; 2008 May; 28(5):729-34. PubMed ID: 18463517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual outcomes with 23-gauge transconjunctival sutureless vitrectomy.
    Tewari A; Shah GK; Fang A
    Retina; 2008 Feb; 28(2):258-62. PubMed ID: 18301031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy.
    Brown JS; Mahmoud TH
    Retina; 2011 Nov; 31(10):1983-7. PubMed ID: 21836531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy.
    Ibarra MS; Hermel M; Prenner JL; Hassan TS
    Am J Ophthalmol; 2005 May; 139(5):831-6. PubMed ID: 15860288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of transconjunctival sutureless 25-gauge vitrectomy with silicone oil infusion.
    Riemann CD; Miller DM; Foster RE; Petersen MR
    Retina; 2007 Mar; 27(3):296-303. PubMed ID: 17460584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of 20-gauge transconjunctival sutureless vitrectomy.
    Spierer O; Siminovsky Z; Loewenstein A; Barak A
    Retina; 2011 Oct; 31(9):1765-71. PubMed ID: 21606890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet and anticoagulation therapy in vitreoretinal surgery.
    Oh J; Smiddy WE; Kim SS
    Am J Ophthalmol; 2011 Jun; 151(6):934-939.e3. PubMed ID: 21411057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term outcome of bimanual 23-gauge transconjunctival sutureless vitrectomy for patients with complicated vitreoretinopathies.
    Park KH; Woo SJ; Hwang JM; Kim JH; Yu YS; Chung H
    Ophthalmic Surg Lasers Imaging; 2010; 41(2):207-14. PubMed ID: 20307039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [23-gauge transconjunctival sutureless vitrectomy: a retrospective study of 164 consecutive cases].
    de Preobrajensky N; Mrejen S; Adam R; Ayello-Scheer S; Gendron G; Rodallec T; Sahel JA; Barale PO
    J Fr Ophtalmol; 2010 Feb; 33(2):99-104. PubMed ID: 20080319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of 20-gauge transconjunctival sutureless vitrectomy.
    Papaefthymiou I; Petropoulos IK; Mangioris G; Mendrinos E; Pournaras CJ
    Ophthalmologica; 2013; 230(4):207-14. PubMed ID: 24029384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of 23- and 25-gauge transconjunctival sutureless vitrectomies for idiopathic macular holes.
    Kusuhara S; Ooto S; Kimura D; Itoi K; Mukuno H; Miyamoto N; Akimoto M; Kuriyama S; Takagi H
    Br J Ophthalmol; 2008 Sep; 92(9):1261-4. PubMed ID: 18614566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and complications of 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy.
    Ozone D; Hirano Y; Ueda J; Yasukawa T; Yoshida M; Ogura Y
    Ophthalmologica; 2011; 226(2):76-80. PubMed ID: 21613797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 23-gauge transconjunctival sutureless vitrectomy: visual outcomes and complications.
    Mateo-Montoya A; Mendrinos E; Tabatabay C; Pournaras CJ
    Semin Ophthalmol; 2011 Mar; 26(2):37-41. PubMed ID: 21469961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 20-gauge transconjunctival sutureless vitrectomy with conventional vitrectomy.
    Lee JE; Kim KH; Kim IK; Jea SY; Kim WS
    Retina; 2010 Oct; 30(9):1496-504. PubMed ID: 20588205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of anticoagulant and antiplatelet agents for patients undergoing peribulbar anesthesia and vitreoretinal surgery.
    Passemard M; Koehrer P; Juniot A; Bron AM; Creuzot-Garcher C
    Retina; 2012 Oct; 32(9):1868-73. PubMed ID: 22495328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of perioperative antiplatelet and anticoagulant therapy for vitreoretinal surgery.
    Ryan A; Saad T; Kirwan C; Keegan DJ; Acheson RW
    Clin Exp Ophthalmol; 2013; 41(4):387-95. PubMed ID: 23094982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sutureless transconjunctival 20-gauge vitrectomy].
    Dassie-Ajdid J; Mahieu L; Mathis V; Arné JL; Auriol S
    J Fr Ophtalmol; 2011 Dec; 34(10):729-36. PubMed ID: 22001624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clear corneal phacoemulsification combined with 25-gauge transconjunctival sutureless vitrectomy and standard 20-gauge vitrectomy for patients with cataract and vitreoretinal diseases.
    Chang CJ; Chang YH; Chiang SY; Lin LT
    J Cataract Refract Surg; 2005 Jun; 31(6):1198-207. PubMed ID: 16039498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 23-Gauge transconjunctival sutureless vitrectomy for retained lens fragments after complicated cataract surgery.
    Horozoglu F; Yanyali A; Macin A; Nohutcu AF; Keskinbora KH
    Retina; 2012 Mar; 32(3):493-8. PubMed ID: 21975952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.